1.23
5.38%
-0.07
시간 외 거래:
1.27
0.04
+3.25%
An 2 Therapeutics Inc (ANTX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
2.76%
18.30
|
18.82 | 18.18 | 16.60 | 16.04 |
Operating Income/Loss |
2.76%
-18.30
|
-18.82 | -18.18 | -16.60 | -16.04 |
Income/Loss From Continuing Operations Before Tax |
1.66%
-16.62
|
-16.90 | -16.71 | -15.80 | -15.32 |
Income/Loss From Continuing Operations After Tax |
1.66%
-16.62
|
-16.90 | -16.71 | -15.80 | -15.32 |
Net Income/Loss
|
1.66%
-16.62
|
-16.90 | -16.71 | -15.80 | -15.32 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1,340%
29.76
|
2.0676 | 25.65 | 19.50 | 19.39 |
Diluted Average Shares |
1,340%
29.76
|
2.0676 | 25.65 | 19.50 | 19.39 |
Basic Earnings Per Share |
7.69%
-0.56
|
-0.52 | -0.65 | -0.81 | -0.79 |
Diluted Earnings Per Share |
7.69%
-0.56
|
-0.52 | -0.65 | -0.81 | -0.79 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):